Back to Search Results
Medical Devices Unitedstates Monitoring Systems Blood

M&A Advisory

Lazard

Full Credential Description

HemoSense. United States. Announced Date 28/06/2005. Closed Date 28/06/2005. Deal value: $19m. Initial public offering. Industry: HemoSense is a company that specializes in medical devices, particularly point-of-care blood coagulation monitoring systems.

Back to Search Contact Business